| Proteogenomics connects somatic mutations to signalling in breast cancer P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ... Nature 534 (7605), 55-62, 2016 | 1674 | 2016 |
| Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 500 | 2021 |
| Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ... Cell 183 (5), 1436-1456. e31, 2020 | 403 | 2020 |
| Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ... Cancer cell 39 (3), 361-379. e16, 2021 | 270 | 2021 |
| A proteogenomic portrait of lung squamous cell carcinoma S Satpathy, K Krug, PMJ Beltran, SR Savage, F Petralia, C Kumar-Sinha, ... Cell 184 (16), 4348-4371. e40, 2021 | 262 | 2021 |
| Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRα gene in the X chromosome pseudoautosomal region 1 M Martinez-Moczygemba, ML Doan, O Elidemir, LL Fan, SW Cheung, ... The Journal of experimental medicine 205 (12), 2711-2716, 2008 | 200 | 2008 |
| Endocrine therapy resistance: new insights JT Lei, M Anurag, S Haricharan, X Gou, MJ Ellis The Breast 48, S26-S30, 2019 | 118 | 2019 |
| ESR1 alterations and metastasis in estrogen receptor positive breast cancer JT Lei, X Gou, S Seker, MJ Ellis Journal of cancer metastasis and treatment 5, 2019 | 117 | 2019 |
| Functional annotation of ESR1 gene fusions in estrogen receptor-positive breast cancer JT Lei, J Shao, J Zhang, M Iglesia, DW Chan, J Cao, M Anurag, P Singh, ... Cell reports 24 (6), 1434-1444. e7, 2018 | 117 | 2018 |
| Neurofibromin is an estrogen receptor-α transcriptional co-repressor in breast cancer ZY Zheng, M Anurag, JT Lei, J Cao, P Singh, J Peng, H Kennedy, ... Cancer cell 37 (3), 387-402. e7, 2020 | 83 | 2020 |
| Loss of MutL disrupts CHK2-dependent cell-cycle control through CDK4/6 to promote intrinsic endocrine therapy resistance in primary breast cancer S Haricharan, N Punturi, P Singh, KR Holloway, M Anurag, J Schmelz, ... Cancer discovery 7 (10), 1168-1183, 2017 | 83 | 2017 |
| Proteogenomic data and resources for pan-cancer analysis Y Li, Y Dou, FDV Leprevost, Y Geffen, AP Calinawan, F Aguet, Y Akiyama, ... Cancer cell 41 (8), 1397-1406, 2023 | 77 | 2023 |
| Proteogenomic markers of chemotherapy resistance and response in triple-negative breast cancer M Anurag, EJ Jaehnig, K Krug, JT Lei, EJ Bergstrom, BJ Kim, TD Vashist, ... Cancer discovery 12 (11), 2586-2605, 2022 | 64 | 2022 |
| Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation Y Geffen, S Anand, Y Akiyama, TM Yaron, Y Song, JL Johnson, ... Cell 186 (18), 3945-3967. e26, 2023 | 63 | 2023 |
| Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets LA Gates, G Gu, Y Chen, AD Rohira, JT Lei, RA Hamilton, Y Yu, ... Oncogene 37 (33), 4581-4598, 2018 | 63 | 2018 |
| JAK kinases control IL-5 receptor ubiquitination, degradation, and internalization M Martinez-Moczygemba, DP Huston, JT Lei Journal of Leucocyte Biology 81 (4), 1137-1148, 2007 | 54 | 2007 |
| DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer R Matsunuma, DW Chan, BJ Kim, P Singh, A Han, AB Saltzman, C Cheng, ... Proceedings of the National Academy of Sciences 115 (51), E11978-E11987, 2018 | 53 | 2018 |
| Pan-cancer proteogenomics connects oncogenic drivers to functional states Y Li, E Porta-Pardo, C Tokheim, MH Bailey, TM Yaron, V Stathias, ... Cell 186 (18), 3921-3944. e25, 2023 | 50 | 2023 |
| Separate endocytic pathways regulate IL-5 receptor internalization and signaling JT Lei, M Martinez-Moczygemba Journal of Leucocyte Biology 84 (2), 499-509, 2008 | 41 | 2008 |
| Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin WW Liang, RJH Lu, RG Jayasinghe, SM Foltz, E Porta-Pardo, Y Geffen, ... Cancer cell 41 (9), 1567-1585. e7, 2023 | 37 | 2023 |
Matthew J. EllisGuardant Health Palo Alto CAVerified email at guardanthealth.com